Sleep disturbances are common in people with cancer — especially those who are undergoing chemotherapy or other types of treatment, or survivors who've been treated in the past.
Difficulty with insomnia, the ability to fall and stay asleep, is reported in 30 to 50 percent of all cancer patients, according to a recent study. Other studies say the rate may actually be much higher — 75 percent of all cancer patients reporting long and short term insomnia.
One thing’s for sure — the lack of sleep can make a difficult situation even more challenging.
Insomnia not only affects your quality of life. It can negatively impact your treatment and increase risks for other physical and mental health problems.
For example, cancer-related fatigue, daytime sleepiness (hypersomnia), anxiety and depression are commonly reported in people who experience sleep disturbances.
Women who are treated for breast cancer may be most affected, and often list sleep disturbances among the most distressing symptoms experienced during chemotherapy.
A joint study by researchers at Laval University Cancer Research Center in Québec, Canada, and the University of California-San Diego found “little distinction between daytime and nighttime activity cycles” in cancer patients prior to and during treatment.
This pattern indicates a disruption in circadian rhythms.
The master internal biological clock located in the brain helps regulate our body’s normal rhythms during the 24-hour cycle, from temperature and hormone levels to the natural sleep-wake cycle. Circadian rhythm disruptions may even contribute to cancer itself.
During chemo, our biological clock gets out of sync, especially during the first round which is most disruptive, according to the study. However, the longer the treatment goes, the more difficult it is to regulate your biological clock.
The authors stated that patients may need cognitive behavioral therapy or bright light therapy to prevent sleep disturbances from becoming chronic. Both types of therapy have been found to be beneficial for breast cancer patients and survivors.